NAMS Menopause Objective
Assessment Final Exam
Practice Questions and
Solutions
70 Practice Questions with Detailed
Rationales North American Menopause
Society Content Areas
Latest Update
Verified Questions, Answers & Explanations
,Question 1: What is the primary endocrine event that marks the onset of
menopause?
A. Increased FSH levels due to loss of ovarian follicular response ✓
B. Decreased prolactin secretion from the anterior pituitary
C. Increased LH levels due to hypothalamic dysfunction
D. Decreased thyroid-stimulating hormone production
Rationale: Menopause is characterized by the depletion of ovarian follicles,
which leads to decreased estradiol production. The loss of negative feedback
from estrogen on the hypothalamus and pituitary results in markedly elevated
FSH levels. FSH is the most sensitive marker of ovarian aging because
inhibin B, produced by granulosa cells, declines early in the menopausal
transition, removing its suppressive effect on FSH. LH also rises but less
dramatically and later than FSH.
Question 2: At what average age does natural menopause occur in
women in the United States?
A. 45 years
B. 51 years ✓
C. 55 years
D. 58 years
Rationale: The average age of natural menopause in the United States is
approximately 51 years, with the normal range being between 45 and 55
years. Menopause occurring before age 45 is considered early menopause,
and before age 40 is classified as premature ovarian insufficiency. Genetic
factors, smoking, and certain medical treatments can influence the timing of
menopause. Understanding the average age helps clinicians identify women
who may be experiencing early or premature menopause requiring additional
evaluation.
,Question 3: Which hormone pattern is most characteristic of the early
menopausal transition (STRAW+ Stage -2)?
A. Consistently elevated FSH with low estradiol throughout the cycle
B. Variable cycle length with intermittent elevated FSH and fluctuating
estradiol ✓
C. Stable FSH and LH levels with progressive decline in progesterone
D. Elevated inhibin B with normal FSH and declining estradiol
Rationale: According to the STRAW+ staging system, the early menopausal
transition (Stage -2) is characterized by increased variability in menstrual
cycle length, defined as a persistent difference of 7 days or more in the
length of consecutive cycles. Hormonally, FSH levels become variable and
may be intermittently elevated, while estradiol levels fluctuate significantly
and can even be higher than in younger women due to increased follicular
activity. This hormonal variability distinguishes the early transition from the
late transition, where FSH is consistently elevated.
, Question 4: What role does anti-Mullerian hormone (AMH) play in
assessing menopausal status?
A. AMH rises significantly during the menopausal transition as ovarian follicles
are depleted
B. AMH reflects the size of the remaining ovarian follicle pool and
declines progressively before menopause ✓
C. AMH is primarily produced by the adrenal glands and increases after
menopause
D. AMH levels remain stable throughout reproductive life and drop abruptly at
menopause
Rationale: Anti-Mullerian hormone (AMH) is produced by granulosa cells of
preantral and small antral follicles and serves as a biomarker of ovarian
reserve. AMH levels decline progressively throughout a woman's
reproductive life, reflecting the diminishing pool of ovarian follicles. Very low
or undetectable AMH levels are predictive of approaching menopause,
typically occurring 5 years before the final menstrual period. Unlike FSH,
which can fluctuate, AMH provides a more stable measure of ovarian reserve
and is useful for predicting the timing of menopause.
Question 5: Which of the following best describes the change in androgen
levels during the menopausal transition?
A. Testosterone levels rise sharply after menopause due to increased adrenal
production
B. Androstenedione and testosterone levels decline gradually, with
most testosterone produced by the ovaries premenopausally ✓
C. DHEA levels increase significantly after menopause to compensate for
estrogen loss
D. Androgen levels remain completely unchanged throughout the menopausal
transition
Rationale: During the menopausal transition, androgen levels, including
androstenedione and testosterone, decline gradually. Before menopause,
approximately 25% of testosterone is produced by the ovaries, 25% by the
adrenals, and 50% by peripheral conversion of androstenedione. After
Assessment Final Exam
Practice Questions and
Solutions
70 Practice Questions with Detailed
Rationales North American Menopause
Society Content Areas
Latest Update
Verified Questions, Answers & Explanations
,Question 1: What is the primary endocrine event that marks the onset of
menopause?
A. Increased FSH levels due to loss of ovarian follicular response ✓
B. Decreased prolactin secretion from the anterior pituitary
C. Increased LH levels due to hypothalamic dysfunction
D. Decreased thyroid-stimulating hormone production
Rationale: Menopause is characterized by the depletion of ovarian follicles,
which leads to decreased estradiol production. The loss of negative feedback
from estrogen on the hypothalamus and pituitary results in markedly elevated
FSH levels. FSH is the most sensitive marker of ovarian aging because
inhibin B, produced by granulosa cells, declines early in the menopausal
transition, removing its suppressive effect on FSH. LH also rises but less
dramatically and later than FSH.
Question 2: At what average age does natural menopause occur in
women in the United States?
A. 45 years
B. 51 years ✓
C. 55 years
D. 58 years
Rationale: The average age of natural menopause in the United States is
approximately 51 years, with the normal range being between 45 and 55
years. Menopause occurring before age 45 is considered early menopause,
and before age 40 is classified as premature ovarian insufficiency. Genetic
factors, smoking, and certain medical treatments can influence the timing of
menopause. Understanding the average age helps clinicians identify women
who may be experiencing early or premature menopause requiring additional
evaluation.
,Question 3: Which hormone pattern is most characteristic of the early
menopausal transition (STRAW+ Stage -2)?
A. Consistently elevated FSH with low estradiol throughout the cycle
B. Variable cycle length with intermittent elevated FSH and fluctuating
estradiol ✓
C. Stable FSH and LH levels with progressive decline in progesterone
D. Elevated inhibin B with normal FSH and declining estradiol
Rationale: According to the STRAW+ staging system, the early menopausal
transition (Stage -2) is characterized by increased variability in menstrual
cycle length, defined as a persistent difference of 7 days or more in the
length of consecutive cycles. Hormonally, FSH levels become variable and
may be intermittently elevated, while estradiol levels fluctuate significantly
and can even be higher than in younger women due to increased follicular
activity. This hormonal variability distinguishes the early transition from the
late transition, where FSH is consistently elevated.
, Question 4: What role does anti-Mullerian hormone (AMH) play in
assessing menopausal status?
A. AMH rises significantly during the menopausal transition as ovarian follicles
are depleted
B. AMH reflects the size of the remaining ovarian follicle pool and
declines progressively before menopause ✓
C. AMH is primarily produced by the adrenal glands and increases after
menopause
D. AMH levels remain stable throughout reproductive life and drop abruptly at
menopause
Rationale: Anti-Mullerian hormone (AMH) is produced by granulosa cells of
preantral and small antral follicles and serves as a biomarker of ovarian
reserve. AMH levels decline progressively throughout a woman's
reproductive life, reflecting the diminishing pool of ovarian follicles. Very low
or undetectable AMH levels are predictive of approaching menopause,
typically occurring 5 years before the final menstrual period. Unlike FSH,
which can fluctuate, AMH provides a more stable measure of ovarian reserve
and is useful for predicting the timing of menopause.
Question 5: Which of the following best describes the change in androgen
levels during the menopausal transition?
A. Testosterone levels rise sharply after menopause due to increased adrenal
production
B. Androstenedione and testosterone levels decline gradually, with
most testosterone produced by the ovaries premenopausally ✓
C. DHEA levels increase significantly after menopause to compensate for
estrogen loss
D. Androgen levels remain completely unchanged throughout the menopausal
transition
Rationale: During the menopausal transition, androgen levels, including
androstenedione and testosterone, decline gradually. Before menopause,
approximately 25% of testosterone is produced by the ovaries, 25% by the
adrenals, and 50% by peripheral conversion of androstenedione. After
